Literature DB >> 2305981

Hyperbaric nitrous oxide as a sole anesthetic agent in humans.

G B Russell1, M T Snider, R B Richard, J L Loomis.   

Abstract

Nitrous oxide (N2O) has been used to produce analgesia and anesthesia for more than 100 yr. However, because of its high MAC value (1.04), general anesthesia with N2O can usually be attained only in a hyperbaric environment. Because of the sparsity of documentation for human physiologic responses to hyperbaric N2O, we studied eight male volunteers at 2 ATA (1520 mm Hg) anesthetized with N2O only for periods of 2-4 h. N2O partial pressures ranged from 836 to 1368 mm Hg. The anesthetic state was associated with tachypnea, tachycardia, increases in systemic blood pressure, mydriasis, diaphoresis, and at times, clonus and opisthotonus. A stable level of physiologic activity was difficult to maintain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305981     DOI: 10.1213/00000539-199003000-00010

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

Review 1.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 2.  Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection.

Authors:  Andrew M Slupe; Jeffrey R Kirsch
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-16       Impact factor: 6.200

3.  Growth suppression of four cancer cells by hyperbaric nitrous oxide and methotrexate.

Authors:  Cheol Hee Jung; Ji Yeon Sim; Wonsik Ahn
Journal:  Korean J Anesthesiol       Date:  2010-01-31

Review 4.  [Nitrous oxide. Sense or nonsense for today's anaesthesia].

Authors:  M E Schönherr; M W Hollmann; B Graf
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

Review 5.  Opisthotonos following propofol: a nonepileptic perspective and treatment strategy.

Authors:  C R Ries; P J Scoates; E Puil
Journal:  Can J Anaesth       Date:  1994-05       Impact factor: 5.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.